Related Experiment Video
Updated: Aug 18, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Atrial fibrillation in the elderly: management update
1Department of Internal Medicine, Cleveland Clinic Foundation.
Insights
Elderly individuals with non-valvular atrial fibrillation face a high embolic stroke risk. Anticoagulation therapies, including warfarin and aspirin, show promise in mitigating this danger.
Area of Science:
- Cardiology
- Neurology
- Geriatrics
Background:
- Non-valvular atrial fibrillation significantly elevates embolic stroke risk in older adults.
- Growing evidence suggests anticoagulation may reduce stroke incidence in this population.
Purpose of the Study:
- To review the evidence on anticoagulation efficacy for stroke prevention in elderly patients with non-valvular atrial fibrillation.
Main Methods:
- Literature review of studies investigating anticoagulation (warfarin, aspirin) for stroke risk reduction.
- Analysis of data pertaining to elderly populations with non-valvular atrial fibrillation.
Main Results:
- Anticoagulation with warfarin or aspirin appears effective in lowering embolic stroke risk.
- Further research is ongoing to solidify these findings.
Conclusions:
- Anticoagulation is a potential strategy for preventing embolic strokes in elderly patients with non-valvular atrial fibrillation.
- Warfarin and aspirin are key therapeutic options under investigation.
Abstract:
Non-valvular atrial fibrillation is associated with a markedly increased risk of embolic stroke in elderly persons. Evidence is accumulating that anticoagulation with warfarin or aspirin may be effective in reducing this risk.
Related Concept Videos
Mitral Regurgitation III: Medical Management
Rheumatic Heart Disease III: Medical Management
Dysrhythmias VI: Management of Dysrhythmias
Heart Failure V: Medical Management
Cardiomyopathy VI: Nursing Management
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

